1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Patients with fatal outcomes^{^a}
Sex Age (yr) Baseline mRS Location Type Size (mm) No. of FDs Cause of Death Survival Time (days)
M 60 3 BT Fusiform 10 1 Ischemic stroke 48 hr after FD treatment 2
M 58 4 BT Fusiform 55 1 Rupture during placement of the FD 7
M 64 2 VB junction Fusiform 90 1 Medullary infarct 15
M 55 3 BT Fusiform 39 3 Stable mRS at discharge; acute brain stem infarct 50
M 57 3 VB junction Fusiform 40 3 Stable mRS at discharge; acute gastrointestinal bleed; clopidogrel was stopped; died of urosepsis 170
M 59 4 VB junction Saccular 55 3 Improved mRS at discharge (mRS 3); follow-up DSA at 7 months; aneurysm patent (>50%); at 8 mo, sudden clinical impairment 242
M 74 3 BT Fusiform 28 2 Stable mRS at discharge; died of pneumonia 388
F 75 3 VB junction Fusiform 30 2 mRS 5 at discharge to a tertiary care facility; died of pneumonia Unknown
F 65 1 Vertebral artery Fusiform 8 1 Stable mRS at discharge; died from complications related to brain tumor treatment Unknown
↵a All patients had presented with unruptured aneurysms.